找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Immunotherapy; Aung Naing,Joud Hajjar Book 2021Latest edition The Editor(s) (if applicable) and The Author(s), under exclusive license to

[復(fù)制鏈接]
樓主: 選民
21#
發(fā)表于 2025-3-25 04:16:48 | 只看該作者
22#
發(fā)表于 2025-3-25 11:25:21 | 只看該作者
Abdulrazzak Zarifa,Juan Lopez-Mattei,Nicolas L. Palaskas,Cezar Iliescu,Jean-Bernard Durand,Peter Y. tinued to be the case despite recent advances in the treatment of acute events, which have proven to decrease disability and improve outcomes. Over recent years, there has been significant growth in the field of acute stroke care and stroke systems of care. This includes improvements in the manageme
23#
發(fā)表于 2025-3-25 14:22:34 | 只看該作者
24#
發(fā)表于 2025-3-25 17:57:31 | 只看該作者
25#
發(fā)表于 2025-3-25 23:54:47 | 只看該作者
Immunotherapy for Melanoma,n, we provide an overview of the results of recent advances in the adjuvant setting for patients with resected stage III and stage IV melanoma, as well as in patients with melanoma brain metastases. Finally, we provide a brief overview of the current research efforts in the field of immuno-oncology for melanoma.
26#
發(fā)表于 2025-3-26 00:16:11 | 只看該作者
27#
發(fā)表于 2025-3-26 07:50:37 | 只看該作者
Immune Checkpoint Inhibitor (ICI)-Related Cardiotoxicity,toxicities related to immunotherapy are reportedly rare, they can be severe and associated with life-threatening conditions such as fulminant myocarditis, hemodynamic instability, and cardiac arrest. We will review the most commonly reported cardiovascular toxicities associated with ICIs and their management.
28#
發(fā)表于 2025-3-26 08:36:35 | 只看該作者
29#
發(fā)表于 2025-3-26 13:16:06 | 只看該作者
Resistance to Immunotherapy: Mechanisms and Means for Overcoming,rucial to understand the pathophysiology of the tumor-immune system interplay and the mechanisms of immune escape in order to circumvent primary and acquired resistance. Here we provide an outline of the most well-defined mechanisms of resistance and shed light on ongoing efforts to reinvigorate immunoreactivity.
30#
發(fā)表于 2025-3-26 16:49:46 | 只看該作者
Renal Toxicity, autoimmune disease with a focus on renal cell cancer in setting of chronic kidney disease (CKD). Transplant rejection in setting of CPI use has been further evaluated with single-center and multicenter retrospective studies, and available data will be presented in this chapter.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 09:24
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
石泉县| 陕西省| 宣化县| 浦东新区| 信阳市| 鹤山市| 大庆市| 晋江市| 新野县| 十堰市| 宁都县| 广安市| 晋中市| 政和县| 舒城县| 巴彦淖尔市| 湘潭市| 闵行区| 石林| 栾城县| 临澧县| 黔南| 大庆市| 太和县| 咸阳市| 盐城市| 柳州市| 斗六市| 宁城县| 仙游县| 海林市| 尤溪县| 辉县市| 南宁市| 万宁市| 屯昌县| 广德县| 扬州市| 鄂温| 枝江市| 铅山县|